| mRNA |
thapsigargin |
gCSI |
pan-cancer |
AAC |
-0.23 |
6e-05 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
9e-05 |
| mRNA |
KIN001-270 |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
0.0003 |
| mRNA |
KIN001-102 |
GDSC1000 |
pan-cancer |
AAC |
0.1 |
0.0004 |
| mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
-0.19 |
0.0004 |
| mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0005 |
| mRNA |
niclosamide |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0007 |
| mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0009 |
| mRNA |
BRD-K07442505 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0009 |
| mRNA |
AZD6244 |
CCLE |
pan-cancer |
AAC |
0.14 |
0.001 |